Background The annual number of hospital admissions and in-hospital deaths due to severe acute lower respiratory infections (ALRI) in young children worldwide is unknown. We aimed to estimate the incidence of admissions and deaths for such infections in children younger than 5 years in 2010.
Introduction
Acute lower respiratory infections (ALRI), such as pneumonia and bronchiolitis, are a leading cause of morbidity and mortality in young children. In 2010, 1·4 million children died because of such infections, 1 resulting in a substantial burden on the health-care system. No systematically established global estimates have been made of the incidence of hospital admissions for severe ALRI in children younger than 5 years. Rudan 2 estimated that worldwide, 7-13% of 156 million yearly pneumonia cases might progress to severe disease and warrant admission. However, these preliminary estimates were based on fi ndings from only 28 communitybased studies of disease incidence, six of which estimated the proportion of severe episodes, and these had variable case ascertainment.
We were aware of additional high-quality data for incidence of and mortality from admissions for severe ALRI. These data were from published and un pub lished hospital-based studies with passive case ascertainmentie, children who reported to the health facility. Therefore, we formed a Severe ALRI Working Group, a consortium of leading researchers in childhood pneumonia working mainly in developing countries, to estimate the incidence of hospital admissions and in-hospital deaths due to severe ALRI in children younger than 5 years in 2010, worldwide and for six WHO regions. Furthermore, we examined how these estimates varied by severity of episode, by sex, by distance from the hospital, and in the period 2008-10 during the infl uenza A H1N1 pandemic.
Methods

Search strategy and selection criteria
We undertook a systematic literature review with various search terms (appendix pp 4-6), hand searched online journals, and scanned the reference lists of identifi ed Infrastructure, Wanfang Data, and Chongqing VIP for studies published in Chinese.
We included studies reporting data for hospital admission for ALRI and severe ALRI in children younger than 5 years, with data for at least 12 consecutive months, and reporting incidence or mortality for at least the fi rst year of life. Although we assessed studies reporting incidence estimates, we included only those with well defi ned catchment populations or estimations of the population at risk. We excluded studies in which the case defi nition was not clearly defi ned or not consistently applied; description of the methods for estimation of the denominator population was not clear; only cause-specifi c ALRI incidence or mortality were reported; only incidence or mortality estimates for ALRI confi rmed by chest radiograph were reported; those in which incidence or mortality were estimated with modelling techniques; or those reporting data by community-based case ascertainment. We applied no language or publication restrictions. Two investigators (HN and PH) did the search in English language databases and extracted data. Any disagreements were resolved after discussion. One investigator (JSFZ) whose fi rst language was Chinese undertook searches and data abstraction from Chinese language databases and validated identifi ed studies in direct discussion with HN. Unpublished studies were identifi ed in meetings of the Severe ALRI Working Group.
The working group agreed on an approach for data analysis and interpretation and formulated common case defi nitions. The group either reanalysed data from their already published work with these case defi nitions or shared hitherto unpublished data from ongoing studies. This method resulted in analysis of substantial unpublished data, which supplemented data from review of published studies (appendix pp 14-16).
Defi nitions
Most investigators used modifi ed versions of WHO case defi nitions for severe pneumonia (appendix pp 17-26). 3 We used the terms severe and very severe ALRI because many young children present with bronchiolitis, which can be clinically indistinguishable from pneumonia. We decided that children with ALRI denoted by cough or diffi culty breathing with increased respiratory rate for age, with or without indrawing of the chest wall who were admitted at the discretion of the attending physician should be referred to as having severe ALRI. We defi ned very severe ALRI as severe ALRI with hypoxaemia, or WHO Integrated Management of Childhood Illness danger signs, or both. Because data for hypoxaemia were limited to health facilities where pulse oximetry was available, we included studies reporting data for children admitted with severe ALRI and any of the danger signs 3 in the category of very severe ALRI (appendix pp [27] [28] [29] [30] . We recognised that children admitted with very severe ALRI would have a more life-threatening illness and regarded these patients as a subset of those with severe ALRI. We designated countries as industrialised or developing on the basis of UNICEF's classifi cation in The State of the World's Children 2012 report. The child population estimates for 2010 are as in the UN Population Division's database, World Population Pro spects: the 2010 revision.
Data imputation
For studies that did not report disease incidence for the full age range (ie, 0-59 months), we used imputation to calculate missing data by use of the median incidence rate ratio (appendix pp 7-8). 4, 5 We did a sensitivity analysis with unimputed data and noted that the fi nal estimates did not diff er signifi cantly. If the duration of the study exceeded 12 months, but was not in exact multiples of 1 year, we calculated and reported the annualised incidence by adjusting for the population at risk.
Statistical analysis
We did a meta-analysis of data for disease incidence and case-fatality ratio and report pooled estimates and 95% CIs. We used the random eff ects model (DerSimonian-Laird method) because of signifi cant heterogeneity in the data (I²>80%, p<0·0005). 6 Because HIV is a major risk factor for admission for severe ALRI, and the prevalence of HIV in children younger than 5 years has decreased substantially and access to highly active antiretroviral treatment has increased greatly in South Africa since 2002 (median year for the study from Soweto, South Africa), 7 we adjusted the incidence (appendix pp 17-26) taking into consideration both determinants and used the adjusted rates when undertaking the meta-analysis (appendix pp 9-11). We used data for the period Jan 1, 1981, to Dec 31, 2010, and estimated the incidence for industrialised and developing countries and for the six WHO regions, and applied these estimates to children younger than 5 years in 2010. We used two approaches to estimate the probable number of children with episodes of severe ALRI who were not admitted and hence (by combining those estimates with our hospital estimates), the total number of severe cases in developing countries in 2010. First, we used data for health-care use (in chil dren with reported signs of pneumonia) from Demographic Health Survey (DHS) and Multi Indicator Cluster Survey (MICS) databases from 81 surveys from developing countries as a proxy for the proportion of children with severe ALRI who sought hospital care.
For the second approach we used data from four hospital studies that recorded all admissions for severe ALRI within the setting of community-based active surveillance of all episodes of ALRI and severe ALRI 3 This approach enabled us to estimate the proportion of children who were actually admitted (appendix p 12). We assessed variation in incidence by case defi nitions for disease severity and by distance from the hospital. We used incidence ratios to compare the diff erence in incidence between boys and girls.
To estimate in-hospital deaths due to severe and very severe ALRI, we applied the meta-estimates of the in-hospital case-fatality ratios to incidence data for admissions for severe and very severe ALRI for developing and industrialised regions. We did a sensitivity analysis to assess whether the case fatality ratio was a function of the disease incidence and noted no such relation across the developing world (appendix pp [44] [45] . This fi nding supports our decision to use a standard ratio (obtained from the random eff ects model) for all developing countries. We did all data analysis with Stata (version 11.2).
Role of the funding source
The funding sources supported a meeting of the Severe ALRI Working Group in Edinburgh, UK (Aug [30] [31] 2010) . The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. HN had full access to all the data in the study and HN and HC had fi nal responsibility for the decision to submit for publication.
Results
We identifi ed 89 hospital-based studies with suitable data for incidence (fi gure 1); 61 were published (of which 14 were in Chinese and two 9, 17 had data for two diff erent populations) and 28 were unpublished (fi gure 2; appendix pp 17-26). 30 studies were in rural populations, 17 in urban populations, and 42 were in a mixture of both. 25 (40%) of 62 studies from developing countries were either cohort studies or were in a demographic sur veillance site; seven (11%) had a welldefi ned catchment area for which we estimated the population with a health-care utilisation survey, and 30 (49%) were undertaken in hospitals with well defi ned catchment areas. Only 43 studies (24 published and 19 unpublished; appendix pp 7-8) reported disease incidence by age group for the full age range and we imputed data for the remaining 46 studies. 19 studies (15 unpublished) reported inci dence specifi cally for neonates (infants aged 0-27 days; appendix pp 31-32). The 62 studies from developing countries reported incidence of hospital admissions for severe ALRI in children aged 0-59 months (about 20 episodes per 1000 children per year; table 1).
Disease incidence was highest in neonates aged 0-27 days (68·6 episodes per 1000 per year, 95% CI 47·8-98·4; appendix pp 31-32) and infants aged 0-11 months (51·8 episodes per 1000 per year, 44·8-59·8). With data from 27 studies in indus trialised countries, estimates of the incidence of admis sions for severe ALRI was about 20 episodes per 1000 children per year in children aged 0-11 months, and about 10 episodes per 1000 children per year in those aged 0-59 months, which translate to about 12 million episodes worldwide in children younger than 5 years in 2010, with disease in neonates contributing to about 6% of this overall burden (table 1). Data from 15 unpublished studies that recorded this information showed that only about 60% of children admitted with ALRI have indrawing of the lower-chest wall (appendix pp 38-39). 36 studies (34 from developing countries) reported the incidence of admissions for very severe ALRI in children aged 0-59 months (appendix pp 27-30). We estimated that the incidence of admissions for very severe ALRI in this age group in developing countries was about fi ve episodes per 1000 children per year, which translates to about 3 million cases worldwide (7) 2 (0) 14 (4) 14 (4) 25 (1) 65 (13) 24 (6) 89 (19) Incidence † 22·6 (15·3-33·4) Data in parentheses are imputed number of studies or 95% CI. ALRI=acute lower respiratory infection. *Data include American Indian and Alaska native populations in the USA because the socioeconomic and demographic risk factors for ALRI in these populations are similar to those in the developing countries. †Data are incidence meta-estimates from random eff ects model. ‡Number of episodes globally in 2010 is the sum of the episodes in children residing in developing and industrialised countries in that year. (table 1) . We estimate that about 15% (95% CI 10·2-20·8) of all infants and 11% (7-16·3) of children aged 12-59 months admitted with severe ALRI have hypoxaemia. However, the prevalence of hypoxaemia in these children is highly variable across study sites and regions (appendix pp [42] [43] .
Findings from 28 unpublished studies show that the incidence of admissions for severe ALRI was higher in boys than in girls for all age groups and regions; this sex diff erence was greatest in studies from South Asia (fi gure 3). We identifi ed two studies that reported data for residence of children with the Geographic Infor mation System, which showed that disease incidence generally decreased with increasing distance from hospital, except at one site in which admission rates were low for children living within 2 km of hospital (appendix p 46).
We identifi ed four unpublished studies that used both active community-based case ascertainment and had a hospital group for passive case ascertainment (appendix p 33). The proportion of children with chest wall indrawing identifi ed in the community that were treated in hospital varied greatly between these studies (median proportion 0·5, IQR 0·4-0·6). We used this proportion and data for health-care use for ALRI from DHS and MICS databases to estimate that about 19 million episodes of severe ALRI occurred in children aged 0-59 months globally in 2010 (fi gure 4). This preliminary estimate is consistent with published and well accepted incidence and mortality estimates and is within the confi dence intervals of the previous global estimate (fi gure 4).
1,2
We sought to describe the variation in incidence of
We identifi ed ten published 11, 14, 21, 24, 35, 40, 41, 63, 64, 66 and 27 unpub lished studies (appendix pp [34] [35] providing data for in-hospital case fatality in children aged younger than 5 years admitted with severe ALRI, and 16 unpublished studies (appendix p 36) reporting case fatality for very severe ALRI. We estimated that the hospital-based case-fatality ratio was 2·3% (95% CI 1·6-3·4; table 2) in children aged 0-59 months admitted with severe, and 6·1% (4·6-8·1) for those with very severe ALRI in developing countries in 2010, with the highest rates reported in studies from Africa; by contrast, estimated case-fatality ratios in industrialised countries were 0·6% (0·4-0·8; table 2) and 3·9% (3·1-4·8), respectively.
We applied the in-hospital meta-estimates of case fatality for the developing and industrialised regions to the incidence meta-estimates for those regions and estimated that worldwide in 2010, severe ALRI resulted in about 0·3 million in-hospital deaths in children aged 0-4 years, and 67% of these deaths were in young children who presented with signs of very severe ALRI on admission (panel). The case-fatality ratio was 9% (95% CI 1-18) higher in girls (p=0·01) aged 0-11 months than in boys of this age, but did not diff er signifi cantly (p=0·49) by gender in children aged 12-59 months, in whom the ratio was 6% (-13 to 22) higher in boys (p=0·49).
Discussion
We estimated that in 2010, there were about 12 million episodes of hospital admissions for severe and 3 million for very severe ALRI. We further estimated that severe or very severe ALRI resulted in about 0·3 million deaths in hospitals in young children. 99% of these deaths were in developing countries, and in-hospital deaths were about 19% (uncertainty range 12-41%, based on extreme combinations of numerator and denominator 95% CI values) of the estimated total number of ALRI deaths in young children in 2010. The incidence of admissions for severe ALRI were more than three times higher in neonates and about 1·3 times higher in infants aged 0-11 months than the overall rate in young children aged 0-59 months. Estimates are very variable within and between countries and regions and across diff erent study periods (table 1, table 2 , appendix pp 17-30). Several factors aff ect these estimates: method of case ascertainment, precise case defi nitions for the various categories of admission, geographical location of the study sites, cultural factors, and health-care seeking behaviour of the population. Hence, the true uncertainties around these estimates are larger than those expressed in a standard 95% CI that we report. We have attempted to reduce these biases by using strict case defi nitions and minimum quality criteria for included studies. Estimates from developing and indus trialised countries are not strictly comparable because case defi nitions in developing countries tend to be based on simple clinical syndromic criteria, with no require ment for results of investigations. Health information systems in developing countries do not typically provide accurate information about the regional and national burden of severe ALRI on hospital services, despite this information being of key importance for the planning of these services. Therefore, such estimates could be useful in the many settings where data are scarce. The incidence metaestimate for admissions of severe ALRI in developing countries derives largely from studies in which the catchment population had fairly good access to care, and where study interventions might have changed healthcare seeking behaviour of participants. We recognise that many children with severe ALRI in developing countries do not receive hospital care. Therefore, our global and regional esti mates are likely to underestimate the true burden of severe ALRI, but rather show the burden of such infection on hospital services, with the assumption that the level of health-care access and use is similar to that in the included 89 studies.
We estimated the extent to which these hospital-based data underestimate the true incidence of severe ALRI in developing countries with poor access to and use of hospital care (fi gure 4). Although based on indicator data from DHS and MICS for seeking of appropriate health care for children with reported signs of ALRI (rather than care sought for severe ALRI), our estimate of severe ALRI in young children receiving hospital care is broadly consistent with that (49%, IQR 36-62%) from the four hospital studies used in the second of our two analytical approaches. 3 Furthermore, our estimates are consistent with those reported elsewhere (fi gure 4). Understanding how these estimates fi t with previously reported estimates of the global burden of acute lower respiratory infection (ALRI) is relevant for development of health policies for control of disease mortality. The dark green boxes show previously reported estimates of the global burden of severe ALRI (based on 28 community-based studies of ALRI morbidity) and the burden of ALRI-related deaths (based on independent data that combined vital registration data and data from multicause mortality studies, mainly with verbal autopsy) in young children. Our study (white boxes), based on data from hospital-based studies, introduces a health systems perspective to these previous estimates, which were based mainly on community based studies. We used the estimate for admissions of severe ALRI and available information about health facility use in diff erent global regions to derive an estimate of the possible cases of severe ALRI in the community (orange boxes). The grey boxes show the burden of childhood cases of severe ALRI not accessing hospital inpatient services.
The high number of severe ALRI episodes mostly shows inadequate care-seeking behaviour or poor access to hospital care, or both, in some settings. For example, many children referred for hospital care do not attend because of cost or cultural factors. 67 This estimate also shows the extent of the large referral burden on hospital services in developing countries, which suggests a need for substantially increased investment in hospital capacity for inpatient and outpatient services, both in terms of human resources and for provision of relevant drugs and supplies for paediatric care. New approaches to increasing of treat ment coverage for severe pneu monia, as defi ned by WHO, in communities that are underserved by hospitals have been eff ective in Asian settings. 68 ,69 WHO recom mendations, based on fi ndings from these controlled trials in Asia 70 for management of cases of WHO severe pneumonia with oral antibiotics at home is one strategy that could be eff ective in some settings.
The analysis in fi gure 4 shows a general consistency in estimates and has important policy implications: although 62% of children manage to reach hospitals, most deaths still take place outside hospitals. This result is attributable to the large diff erence in case fatality between hospital-treated and non-hospital-treated severe ALRI. Furthermore, the fi ndings suggest that even if very high rates of access and care seeking were achieved, the number of deaths might still be high. In addition to strategies to increase coverage of pnemococcal vaccination in young children, scaling up of community case management of childhood ALRI (including management of WHO severe pneumonia when appropriate) should be regarded as an eff ective strategy that could help to reduce the remaining burden of mortality, remove the burden on hospital services, and improve equity in reduction of child mortality.
Findings from two studies (appendix p 46) showing that incidence of admissions for severe ALRI de creased with increasing distance from the hospital were consistent with previous reports 71, 72 and emphasise that access to hospital care is an important determinant of deaths from pneumonia in children in developing countries. We noted a consistently higher incidence of admissions for severe ALRI in boys than in girls. Although this increased risk could be attributable to the smaller airway size in young boys than in young girls, 73 the substantially height ened sex diff erences in South Asian studies (India, Pakistan, and Bangladesh) probably shows the importance of cultural factors, such as preference in seeking medical care for boys. 74, 75 Global burden of disease estimates tend not to include estimates by sex for child mortality from pneumonia; therefore, to what extent sex diff erences aff ect pneumonia mortality is uncertain. These diff er ences, especially those in South Asia, merit further study and programmatic attention because they could represent substantial health inequity. Investigators of future epi demi ological studies should make increased eff orts to gather, analyse, and report gender-specifi c data to increase the attention given to this important issue.
Hypoxaemia is a key predictor of ALRI mortality 76 and an important indicator of severity. Hypoxaemia prevalence estimates were variable across study sites and defi ned by factors such as altitude of the study site. 12·6% of severe cases had hypoxaemia, which is consistent with fi ndings from a systematic review and meta-analysis. 76 Our estimates suggest that every year about 1·5 million children admitted with severe ALRI need oxygen treat ment. The estimates further emphasise and quantify the need for pulse oximetry equipment and related staff training for identifi cation of children with hypoxaemia, because clinical signs are poor indicators of this complication. 76 We estimate that about a third of all admissions for severe ALRI meet clinical criteria for very severe ALRI and need second-line parenteral treatment with antibiotics; however, substantial heterogeneity exists. In general, the incidence estimates for African countries are about fi ve times higher than those for other developing regions. This fi nding could show poor access to care in these regions, leading to delays in antibiotics and frequent progression to more severe disease. Furthermore, the estimates are consistent with severe falciparum malaria in endemic areas being misclassifi ed as severe ALRI in settings with few diagnostic facilities. 77 In 2010, during the infl uenza A H1N1 pandemic, our estimates showed an increase in the incidence of admissions for severe and very severe ALRI com pared with estimates from the same sites for 2008. This fi nding could result from increased community aware ness about respiratory illness during the pandemic period, leading to increased care seeking and hospital admission or because of an annual variation in the incidence of severe ALRI. However, the increase in admission could be partly explained by disease due to the pandemic predisposing to subsequent bacterial pneumonias. 78 This relation needs to be investigated because the ability of health services to respond to a substantial increase in childhood severe ALRI could be an important component of pandemic infl uenza preparedness and for reducing of infl uenzarelated childhood mortality.
No data are available for several regions worldwide with large high-burden populations 79 -eg, WHO's Eastern Mediterranean region and much of sub-Saharan Africa. Our estimates of the incidence of admissions for severe ALRI could be used to assess the needs for equipment, such as pulse oximeters and oxygen concentrators, and for drugs in hospitals in developing countries where health information systems cannot supply these data. The fairly low estimated percentage of overall deaths that take place in hospital emphasises that access to hospital care is inadequate in many developing countries. Investment should be made to improve such access and to introduce new strategies, such as community case management for cases presently classifi ed as WHO severe pneumonia. Access to care, sex inequities in care seeking, and appropriate case management of children with severe and very severe pneumonia needs urgent assessment if further reductions in childhood deaths from pneumonia are to be achieved.
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